CANTEL | Early Breast Cancer Detection. Reinvented.
CANTEL is India's first and only miRNA-based blood test for early breast cancer screening.
A simple blood test. Zero discomfort.
CANTEL detects breast cancer as early as cellular changes set in, when the likelihood of reversible is the highest and least expensive to treat.
Our globally patented technology, clinically validated across all stages and grades, is non-invasive and backed by leading oncologists.
By catching cancer early, we help protect women and families from the emotional, physical, and financial toll of late-stage treatment.
Why CANTEL matters:
- Early detection can support recovery through lifestyle changes
- Non-invasive & culturally inclusive; no stigma, no pain
- Saves lives & costs; late-stage cancer treatment is much more expensive
CANTEL makes early detection a reality.
Let’s change how India screens for breast cancer.
Company Details
- Employees
- 1
- Industry
- Medical Practices
- NAICS
-
Ambulatory Health Care ServicesOffices of Other Health PractitionersOutpatient Care CentersOther Ambulatory Health Care ServicesOffices of All Other Health PractitionersOutpatient Mental Health and Substance Abuse CentersAll Other Ambulatory Health Care ServicesOffices of PodiatristsBlood and Organ BanksAll Other Miscellaneous Ambulatory Health Care Services
- Keywords
- Noida.
Cantel India Questions
Cantel India's LinkedIn profile is https://www.linkedin.com/company/cantelindia
Cantel India has
1 employees.
View email and phone details for 1
employees at Cantel India.
Cantel India's industry is
Medical Practices
Cantel India's top competitors are
Lap Ventures,
Bitsio Inc.,
Intech Systems : Microsoft Solutions Partner,
Aragen Life Sciences,
Biocon Biologics,
Cantel Medical,
Bose Fellowship,
Her Circle Official,
Unconsult,
Gus Global Services India Pvt. Ltd..
Cantel India's categories are Medical Practices
